Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Onkure Therapeutics Inc OKUR

Healthcare Biotechnology
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the... see more

Recent & Breaking News (NDAQ:OKUR)

Reneo Pharmaceuticals Hosting Key Opinion Leader Webinar on McArdle Disease and other Genetic Mitochondrial Myopathies

GlobeNewswire September 28, 2021

Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire September 9, 2021

Reneo Pharmaceuticals Reports Second Quarter 2021 Financial Results

GlobeNewswire August 11, 2021

Reneo Pharmaceuticals Announces First Patient Dosed in the STRIDE Study

GlobeNewswire July 28, 2021

Reneo Pharmaceuticals Announces Partial Waiver of Lock-Up Restriction

GlobeNewswire July 9, 2021

Reneo Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference

GlobeNewswire July 7, 2021

Reneo Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices

GlobeNewswire June 29, 2021

Reneo Pharmaceuticals Reports First Quarter 2021 Financial Results

GlobeNewswire May 20, 2021

Reneo Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

GlobeNewswire May 19, 2021

Reneo Pharmaceuticals Announces Pricing of Initial Public Offering

GlobeNewswire April 8, 2021

Podcasts